Ryan's District Boards

Study Finds No Heart Valve Benefits From Vytorin

Schering-Plough and Merck's cholesterol drug Vytorin doesn't lower the risk of major heart valve problems and need for related surgical procedures, according to a large-scale study.<img src="http://feeds.feedburner.com/~r/foxnews/health/~4/341801913" height="1" width="1"/>

http://feeds.feedburner.com/~r/foxnews/health/~3/341801913/0,2933,387721,00.html